Research programme: therapeutic hepatitis B vaccine - Vaxine
Latest Information Update: 23 Oct 2013
At a glance
- Originator Vaxine
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hepatitis B
Most Recent Events
- 23 Oct 2013 The therapeutic vaccine is still in preclinical development for the treatment of Hepatitis B in Australia.
- 27 Nov 2006 Preclinical trials in Hepatitis B treatment in Australia (Injection)